Eli Lilly navigates complex regulatory waters: upcoming FDA decisions, Medicare price negotiations under the Inflation Reduction Act, and patent battles with compounding pharmacies. Our analysis examines the risks and opportunities. https://post.kapualabs.com/2tu3smr8 #Pharmaceuticals #RegulatoryAffairs #Investing $LLY